BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 23395341)

  • 1. The impact of HLA-E polymorphisms on relapse following allogeneic hematopoietic stem cell transplantation.
    Hosseini E; Schwarer AP; Jalali A; Ghasemzadeh M
    Leuk Res; 2013 May; 37(5):516-9. PubMed ID: 23395341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of HLA-E polymorphisms in graft-versus-host disease following HLA-E matched allogeneic hematopoietic stem cell transplantation.
    Hosseini E; Schwarer AP; Ghasemzadeh M
    Iran J Allergy Asthma Immunol; 2012 Mar; 11(1):15-21. PubMed ID: 22427472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-E polymorphism and clinical outcome after allogeneic hematopoietic stem cell transplantation in Egyptian patients.
    Mossallam GI; Fattah RA; El-Haddad A; Mahmoud HK
    Hum Immunol; 2015 Mar; 76(2-3):161-5. PubMed ID: 25543014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA-E polymorphisms in hematopoietic stem cell transplantation.
    Fürst D; Bindja J; Arnold R; Herr W; Schwerdtfeger R; Müller CH; Recker K; Schrezenmeier H; Mytilineos J
    Tissue Antigens; 2012 Apr; 79(4):287-90. PubMed ID: 22256791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A defined donor activating natural killer cell receptor genotype protects against leukemic relapse after related HLA-identical hematopoietic stem cell transplantation.
    Verheyden S; Schots R; Duquet W; Demanet C
    Leukemia; 2005 Aug; 19(8):1446-51. PubMed ID: 15973456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KIR ligands and prediction of relapse after unrelated donor hematopoietic cell transplantation for hematologic malignancy.
    Hsu KC; Gooley T; Malkki M; Pinto-Agnello C; Dupont B; Bignon JD; Bornhäuser M; Christiansen F; Gratwohl A; Morishima Y; Oudshoorn M; Ringden O; van Rood JJ; Petersdorf E;
    Biol Blood Marrow Transplant; 2006 Aug; 12(8):828-36. PubMed ID: 16864053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [IL-18 single nucleotide polymorphisms in hematologic malignancies with HLA matched sibling donor allogeneic hematopoietic stem cell transplantation].
    Cai X; Song A; Wang H; Zhang P; Zhang G; Yang F; Wei J; Ma Q; Yan Z; Jiang E; Huang Y; Yang D; Wang M; He Y; Han M; Feng S
    Zhonghua Xue Ye Xue Za Zhi; 2014 Mar; 35(3):215-20. PubMed ID: 24666487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do human leukocyte antigen E polymorphisms influence graft-versus-leukemia after allogeneic hematopoietic stem cell transplantation?
    Hosseini E; Schwarer AP; Ghasemzadeh M
    Exp Hematol; 2015 Mar; 43(3):149-57. PubMed ID: 25434712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic polymorphism and allogeneic hematopoietic transplantation outcome.
    Mullighan CG; Petersdorf EW
    Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 1):19-27. PubMed ID: 16399580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Related HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion: observations of a single Chinese center.
    Huang X; Liu D
    Clin Transpl; 2011; ():237-45. PubMed ID: 22755417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient HSP70-hom TG haplotype is associated with decreased transplant-related mortality and improved survival after sibling HLA-matched hematopoietic stem cell transplantation.
    Kim I; Kim JH; Rhee JY; Kim JW; Cho HJ; Cho EY; Lee JE; Hong YC; Park SS; Yoon SS; Park MH; Park S; Kim BK
    Clin Transplant; 2010; 24(4):459-66. PubMed ID: 19758266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RANTES polymorphisms and the risk of graft-versus-host disease in human leukocyte antigen-matched sibling allogeneic hematopoietic stem cell transplantation.
    Shin DY; Kim I; Kim JH; Lee YG; Kang EJ; Cho HJ; Lee KH; Kim HJ; Park EH; Lee JE; Bae JY; See CJ; Yoon SS; Park SS; Han KS; Park MH; Hong YC; Park S; Kim BK
    Acta Haematol; 2013; 129(3):137-45. PubMed ID: 23207898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of HLA-E*0103 homozygosity on survival after allogeneic hematopoietic stem-cell transplantation.
    Danzer M; Polin H; Pröll J; Haunschmid R; Hofer K; Stabentheiner S; Hackl C; Kasparu H; König J; Hauser H; Binder M; Weiss R; Gabriel C; Krieger O
    Transplantation; 2009 Aug; 88(4):528-32. PubMed ID: 19696636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of vitamin D receptor gene polymorphisms on clinical outcomes of HLA-matched sibling hematopoietic stem cell transplantation.
    Cho HJ; Shin DY; Kim JH; Bae JY; Lee KH; See CJ; Kim N; Park EK; Ra EK; Lee JE; Hong YC; Kim HK; Park SS; Yoon SS; Lee DS; Han KS; Park MH; Park S; Kim BK; Kim I
    Clin Transplant; 2012; 26(3):476-83. PubMed ID: 22035017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Role of polymorphic adhesion molecules in the development of graft-versus-leukemia effect after HLA-matched allogeneic stem cell transplantation].
    Shiobara S; Sato H; Furukawa T; Tsukada J; Yasue S; Takeda H; Togawa A; Taira M; Sakai Y; Aizawa Y; Nakao S
    Rinsho Ketsueki; 2004 Jul; 45(7):518-23. PubMed ID: 15359910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of natural killer cell dose and donor killer-cell immunoglobulin-like receptor (KIR) genotype on outcome following human leucocyte antigen-identical haematopoietic stem cell transplantation.
    Clausen J; Wolf D; Petzer AL; Gunsilius E; Schumacher P; Kircher B; Gastl G; Nachbaur D
    Clin Exp Immunol; 2007 Jun; 148(3):520-8. PubMed ID: 17493020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Donor KIR3DL1/3DS1 gene and recipient Bw4 KIR ligand as prognostic markers for outcome in unrelated hematopoietic stem cell transplantation.
    Gagne K; Busson M; Bignon JD; Balère-Appert ML; Loiseau P; Dormoy A; Dubois V; Perrier P; Jollet I; Bois M; Masson D; Moine A; Absi L; Blaise D; Charron D; Raffoux C;
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1366-75. PubMed ID: 19822295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hematopoietic stem cell transplantation: killer immunoglobulin-like receptor component.
    Hsu KC; Pinto-Agnello C; Gooley T; Malkki M; Dupont B; Petersdorf EW
    Tissue Antigens; 2007 Apr; 69 Suppl 1():42-5. PubMed ID: 17445161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kappa immunoglobulin light chain polymorphisms and survival after allogeneic transplantation for B-cell malignancies: a potential graft-vs-leukaemia target.
    Etto TL; Stewart LA; Muirhead J; Bailey M; Schwarer AP
    Tissue Antigens; 2007 Jan; 69(1):56-61. PubMed ID: 17212708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clonal evolution including partial loss of human leukocyte antigen genes favoring extramedullary acute myeloid leukemia relapse after matched related allogeneic hematopoietic stem cell transplantation.
    Stölzel F; Hackmann K; Kuithan F; Mohr B; Füssel M; Oelschlägel U; Thiede C; Röllig C; Platzbecker U; Schetelig J; Illmer T; Schaich M; Seliger B; Hartmann A; Baretton G; Zietz C; Ehninger G; Schrock E; Bornhäuser M
    Transplantation; 2012 Apr; 93(7):744-9. PubMed ID: 22314337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.